Screening Women With Prior HPV for Anal Neoplasia

ID#: NCT05217940

Age: 45 years - 66+

Gender: Female

Healthy Subjects: No

Study Phase: N/A

Recruitment Status: Recruiting

Start Date: March 02, 2022

End Date: August 01, 2026

Contact Information:
Nadia Zubair
217-714-8111
Summary: The goal of this single arm trial is to prospectively evaluate screening methods for anal cancer precursors in HIV uninfected women with a history of lower genital tract neoplasias and cancers.
Eligibility:

Inclusion Criteria:

- Women with a history of pathologically proven high-grade genital HPV-associated neoplastic disease (cervical intraepithelial neoplasia 2+, vulvar intraepithelial neoplasia 2+, or vaginal intraepithelial neoplasia 2+, or history of non-metastatic cervical, vaginal or vulvar cancer)

- Documented HIV seronegativity Aged less than or equal to 45 years

- Seen in the Mount Sinai Health System (MSHS) or the Harris Health System (HHS) in Houston

- English or Spanish speaking